[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.178.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1952

TREATMENT OF RETROLENTAL FIBROPLASIA WITH VITAMIN E, CORTICOTROPIN (ACTH), AND CORTISONE

Author Affiliations

WILMINGTON, DEL.; PHILADELPHIA
From the Delaware Hospital, Wilmington, Del. (Dr. LaMotte), and the Department of Ophthalmology, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, and the Children's Hospital of Philadelphia (Drs. Tyner and Scheie).

AMA Arch Ophthalmol. 1952;47(5):556-569. doi:10.1001/archopht.1952.01700030570002
Abstract

THIS paper presents observations made during the treatment of 17 premature infants with vitamin E and of 21 premature infants with corticotropin (ACTH) or cortisone. We have concluded from these experiences that none of these substances offers an effective means of therapy for the condition. Although it is difficult, because of the unpredictable course of the disease and the small number of patients available, to state that these substances may not favorably influence the condition in certain instances, they are certainly not curative in all. The disease progressed to blindness in some patients in spite of therapy with vitamin E, corticotropin, or cortisone, while in others it became arrested or even regressed to normal. We do believe, however, that further therapeutic trial of these substances is justified until sufficient evidence has accumulated to indicate their complete ineffectiveness or until a truly satisfactory means of treatment is available. No danger accompanies

First Page Preview View Large
First page PDF preview
First page PDF preview
×